In Vitro and In Vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2) , S313-S322
Abstract
To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinaKeywords
This publication has 44 references indexed in Scilit:
- Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman PrimatesJournal of Virology, 2007
- Canine Distemper Virus Uses both the Anterograde and the Hematogenous Pathway for NeuroinvasionJournal of Virology, 2006
- Molecular Determinants of Ebola Virus Virulence in MicePLOS Pathogens, 2006
- Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or ReplicationJournal of Virology, 2006
- Receptor (SLAM [CD150]) Recognition and the V Protein Sustain Swift Lymphocyte-Based Invasion of Mucosal Tissue and Lymphatic Organs by a MorbillivirusJournal of Virology, 2006
- Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30Journal of Virology, 2006
- Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino OligomersPLOS Pathogens, 2006
- Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell CultureJournal of Virology, 2005
- Development of a New Vaccine for the Prevention of Lassa FeverPLOS Medicine, 2005
- Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of ExpressionJournal of Virology, 2002